Main image
20th March
2008
written by help4

“A US company is set to begin a trial of a vaccine which it claims halts the progress of multiple sclerosis. PharmaFrontiers is to test its tailor-made vaccine on 100 patients with MS, after a small-scale study showed promise. The degenerative disease attacks the nervous system and affects 2.5m people worldwide, of which 1% die each year.”

read more | digg story

nervous system

Del.icio.us Tags:

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • email
  • Print
  • StumbleUpon
  • YahooMyWeb

Leave a Reply